Liquid biopsy: Precise diagnosis and therapy for cholangiocarcinoma

Si-Qin Wang; Chu-Xing Chai; Bi-Rong Wang; Feng Zhu; Dan Shang; Min Li

doi:10.4251/wjgo.v14.i1.362

Liquid biopsy: Precise diagnosis and therapy for cholangiocarcinoma

World J Gastrointest Oncol. 2022 Jan 15;14(1):362-365. doi: 10.4251/wjgo.v14.i1.362.

Authors

Si-Qin Wang¹, Chu-Xing Chai², Bi-Rong Wang³, Feng Zhu¹, Dan Shang⁴, Min Li²

Affiliations

¹ Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.
² Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.
³ Department of Breast and Thyroid Surgery, Wuhan Fourth Hospital; Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
⁴ Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China. danshang@hust.edu.cn.

Abstract

The following letter to the editor highlights the review titled "Liquid biopsy in cholangiocarcinoma: Current status and future perspective" in World J Gastrointest Oncol 2021; 13: 332-350. It is necessary to realize individualized therapy to improve the clinical prognosis of patients with cholangiocarcinoma.

Keywords: Cholangiocarcinoma; Diagnosis; Liquid biopsy; Precision medicine; Therapy.